Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Chandrajit P Raut, M.D.

Title
Institution
Department
Address
Phone

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01EB017722 (COLSON, YOLONDA L) Jan 14, 2016 - Nov 30, 2019
    NIH/NIBIB
    Efficacy and Safety of a Novel, Implantable Drug-eluting Film in Sarcoma
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Raut CP, Espat NJ, Maki RG, Araujo DM, Trent J, Williams TF, Purkayastha DD, DeMatteo RP. Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial. JAMA Oncol. 2018 Nov 01; e184060. PMID: 30383140.
    View in: PubMed
  2. Fairweather M, Raut CP. ASO Author Reflections: Rationale for Organ Resection for Retroperitoneal Sarcomas. Ann Surg Oncol. 2018 Oct 30. PMID: 30377921.
    View in: PubMed
  3. Mahvi DA, Liu R, Grinstaff MW, Colson YL, Raut CP. Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies. CA Cancer J Clin. 2018 Nov; 68(6):488-505. PMID: 30328620.
    View in: PubMed
  4. Raut CP, Bonvalot S, Gronchi A. A call to action: why sarcoma surgery needs to be centralized. Cancer. 2018 Oct 14. PMID: 30317538.
    View in: PubMed
  5. Mella JR, Ross KM, Li GZ, Pomahac B, Raut CP, Orgill DP. Cutaneous Breast Radiation-associated Angiosarcoma: Anterior Chest Wall Reconstruction Options Following Extra-radical Resection. Plast Reconstr Surg Glob Open. 2018 Sep; 6(9):e1938. PMID: 30349797.
    View in: PubMed
  6. Lyu HG, Stein LA, Saadat LV, Phicil SN, Haider A, Raut CP. Assessment of the Accuracy of Disease Coding Among Patients Diagnosed With Sarcoma. JAMA Oncol. 2018 Sep 01; 4(9):1293-1295. PMID: 30098150.
    View in: PubMed
  7. Fairweather M, Balachandran VP, Li GZ, Bertagnolli MM, Antonescu C, Tap W, Singer S, DeMatteo RP, Raut CP. Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors: A 2-institutional Analysis. Ann Surg. 2018 Aug; 268(2):296-302. PMID: 28448384.
    View in: PubMed
  8. Gronchi A, Crago A, Raut CP. Minimally Invasive Surgery for Retroperitoneal Sarcoma: Just Because We Can Does Not Mean We Should. Ann Surg Oncol. 2018 Aug; 25(8):2129-2131. PMID: 29948424.
    View in: PubMed
  9. Hemming ML, Lawlor MA, Zeid R, Lesluyes T, Fletcher JA, Raut CP, Sicinska ET, Chibon F, Armstrong SA, Demetri GD, Bradner JE. Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcome. Proc Natl Acad Sci U S A. 2018 06 19; 115(25):E5746-E5755. PMID: 29866822.
    View in: PubMed
  10. MacNeill AJ, Gronchi A, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Cannell A, Jakob J, Haas RL, Szacht M, Fiore M, Casali PG, Pollock RE, Barretta F, Raut CP, Strauss DC. Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group. Ann Surg. 2018 May; 267(5):959-964. PMID: 28394870.
    View in: PubMed
  11. Fairweather M, Cavnar MJ, Li GZ, Bertagnolli MM, DeMatteo RP, Raut CP. Prediction of morbidity following cytoreductive surgery for metastatic gastrointestinal stromal tumour in patients on tyrosine kinase inhibitor therapy. Br J Surg. 2018 May; 105(6):743-750. PMID: 29579329.
    View in: PubMed
  12. Fairweather M, Gonzalez RJ, Strauss D, Raut CP. Current principles of surgery for retroperitoneal sarcomas. J Surg Oncol. 2018 Jan; 117(1):33-41. PMID: 29315649.
    View in: PubMed
  13. Erstad DJ, Raut CP. Amputation for Sarcoma: Revisiting a 19th Century Treatment in the 21st Century. Ann Surg Oncol. 2018 Feb; 25(2):351-353. PMID: 29181684.
    View in: PubMed
  14. Erstad DJ, Ready J, Abraham J, Ferrone ML, Bertagnolli MM, Baldini EH, Raut CP. Amputation for Extremity Sarcoma: Contemporary Indications and Outcomes. Ann Surg Oncol. 2018 Feb; 25(2):394-403. PMID: 29168103.
    View in: PubMed
  15. Fallahian F, Ardestani A, Pranckevicius E, Raut CP, Tavakkoli A, Sheu EG. The impact of lipomatous tumors on type 2 diabetes: are adipose-derived tumors metabolically active? J Surg Res. 2018 Feb; 222:48-54. PMID: 29273375.
    View in: PubMed
  16. Fairweather M, Wang J, Jo VY, Baldini EH, Bertagnolli MM, Raut CP. Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection. Ann Surg Oncol. 2018 Jan; 25(1):98-106. PMID: 29067605.
    View in: PubMed
  17. Royce TJ, Punglia RS, Chen AB, Patel SA, Thornton KA, Raut CP, Baldini EH. Cost-Effectiveness of Surveillance for Distant Recurrence in Extremity Soft Tissue Sarcoma. Ann Surg Oncol. 2017 Oct; 24(11):3264-3270. PMID: 28718037.
    View in: PubMed
  18. Raut CP. A Rational Approach to Surgery for Retroperitoneal Sarcomas: Extent of Resection Tailored to Histologic Findings. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):273. PMID: 28463148.
    View in: PubMed
  19. Pretz JL, Barysauskas CM, George S, Hornick JL, Raut CP, Chen YE, Marcus KJ, Choy E, Hornicek F, Ready JE, DeLaney TF, Baldini EH. Localized Adult Ewing Sarcoma: Favorable Outcomes with Alternating Vincristine, Doxorubicin, Cyclophosphamide, and Ifosfamide, Etoposide (VDC/IE)-Based Multimodality Therapy. Oncologist. 2017 10; 22(10):1265-1270. PMID: 28550026.
    View in: PubMed
  20. Callegaro D, Miceli R, Mariani L, Raut CP, Gronchi A. Soft tissue sarcoma nomograms and their incorporation into practice. Cancer. 2017 Aug 01; 123(15):2802-2820. PMID: 28493287.
    View in: PubMed
  21. Li GZ, Fairweather M, Wang J, Orgill DP, Bertagnolli MM, Raut CP. Cutaneous Radiation-associated Breast Angiosarcoma: Radicality of Surgery Impacts Survival. Ann Surg. 2017 04; 265(4):814-820. PMID: 28267696.
    View in: PubMed
  22. Keung EZ, Raut CP. Management of Gastrointestinal Stromal Tumors. Surg Clin North Am. 2017 Apr; 97(2):437-452. PMID: 28325196.
    View in: PubMed
  23. Schaefer IM, Wang Y, Liang CW, Bahri N, Quattrone A, Doyle L, Mariño-Enríquez A, Lauria A, Zhu M, Debiec-Rychter M, Grunewald S, Hechtman JF, Dufresne A, Antonescu CR, Beadling C, Sicinska ET, van de Rijn M, Demetri GD, Ladanyi M, Corless CL, Heinrich MC, Raut CP, Bauer S, Fletcher JA. MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation. Nat Commun. 2017 03 08; 8:14674. PMID: 28270683.
    View in: PubMed
  24. Schaefer IM, Hornick JL, Barysauskas CM, Raut CP, Patel SA, Royce TJ, Fletcher CDM, Baldini EH. Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):375-383. PMID: 28463157.
    View in: PubMed
  25. George S, Miao D, Demetri GD, Adeegbe D, Rodig SJ, Shukla S, Lipschitz M, Amin-Mansour A, Raut CP, Carter SL, Hammerman P, Freeman GJ, Wu CJ, Ott PA, Wong KK, Van Allen EM. Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma. Immunity. 2017 02 21; 46(2):197-204. PMID: 28228279.
    View in: PubMed
  26. MacNeill AJ, Miceli R, Strauss DC, Bonvalot S, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Cannell A, Jakob J, Haas RL, Szacht M, Fiore M, Casali PG, Pollock RE, Raut CP, Gronchi A, Swallow CJ. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group. Cancer. 2017 06 01; 123(11):1971-1978. PMID: 28152173.
    View in: PubMed
  27. Fairweather M, Wang J, Jo VY, Baldini EH, Bertagnolli MM, Raut CP. Incidence and Adverse Prognostic Implications of Histopathologic Organ Invasion in Primary Retroperitoneal Sarcoma. J Am Coll Surg. 2017 May; 224(5):876-883. PMID: 28147251.
    View in: PubMed
  28. Patel SA, Royce TJ, Barysauskas CM, Thornton KA, Raut CP, Baldini EH. Surveillance Imaging Patterns and Outcomes Following Radiation Therapy and Radical Resection for Localized Extremity and Trunk Soft Tissue Sarcoma. Ann Surg Oncol. 2017 Jun; 24(6):1588-1595. PMID: 28058559.
    View in: PubMed
  29. Fiore M, Raut CP, Gronchi A. Are We Allowed to Limit Surgical Aggressiveness With Small Rectal Gastrointestinal Stromal Tumors? Ann Surg Oncol. 2017 May; 24(5):1153-1156. PMID: 27900631.
    View in: PubMed
  30. Keung EZ, Fairweather M, Raut CP. Surgical Management of Metastatic Disease. Surg Clin North Am. 2016 Oct; 96(5):1175-92. PMID: 27542649.
    View in: PubMed
  31. Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El-Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G, Awada A, Banerjee S, Bhatia S, Bogaerts J, Buckner J, Cardoso F, Casali P, Chu E, Close JL, Coiffier B, Connolly R, Coupland S, De Petris L, De Santis M, de Vries EG, Dizon DS, Duff J, Duska LR, Eniu A, Ernstoff M, Felip E, Fey MF, Gilbert J, Girard N, Glaudemans AW, Gopalan PK, Grothey A, Hahn SM, Hanna D, Herold C, Herrstedt J, Homicsko K, Jones DV, Jost L, Keilholz U, Khan S, Kiss A, Köhne CH, Kunstfeld R, Lenz HJ, Lichtman S, Licitra L, Lion T, Litière S, Liu L, Loehrer PJ, Markham MJ, Markman B, Mayerhoefer M, Meran JG, Michielin O, Moser EC, Mountzios G, Moynihan T, Nielsen T, Ohe Y, Öberg K, Palumbo A, Peccatori FA, Pfeilstöcker M, Raut C, Remick SC, Robson M, Rutkowski P, Salgado R, Schapira L, Schernhammer E, Schlumberger M, Schmoll HJ, Schnipper L, Sessa C, Shapiro CL, Steele J, Sternberg CN, Stiefel F, Strasser F, Stupp R, Sullivan R, Tabernero J, Travado L, Verheij M, Voest E, Vokes E, Von Roenn J, Weber JS, Wildiers H, Yarden Y. ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open. 2016; 1(5):e000097. PMID: 27843641.
    View in: PubMed
  32. Raut CP. Preface. Surg Oncol Clin N Am. 2016 10; 25(4):xv-xvii. PMID: 27591505.
    View in: PubMed
  33. Nishida T, Goto O, Raut CP, Yahagi N. Diagnostic and treatment strategy for small gastrointestinal stromal tumors. Cancer. 2016 Oct 15; 122(20):3110-3118. PMID: 27478963.
    View in: PubMed
  34. Gronchi A, Strauss DC, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Cannell A, Jakob J, Haas RL, Szacht M, Fiore M, Casali PG, Pollock RE, Raut CP. Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group. Ann Surg. 2016 May; 263(5):1002-9. PMID: 26727100.
    View in: PubMed
  35. Raut CP, Miceli R, Strauss DC, Swallow CJ, Hohenberger P, van Coevorden F, Rutkowski P, Fiore M, Callegaro D, Casali PG, Haas RL, Hayes AJ, Honore C, Cannell AJ, Jakob J, Szacht M, Fairweather M, Pollock RE, Bonvalot S, Gronchi A. External validation of a multi-institutional retroperitoneal sarcoma nomogram. Cancer. 2016 May 01; 122(9):1417-24. PMID: 26916507.
    View in: PubMed
  36. Keung EZ, Fairweather M, Raut CP. The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors. Curr Treat Options Oncol. 2016 Feb; 17(2):8. PMID: 26820287.
    View in: PubMed
  37. Fairweather M, Keung E, Raut CP. Neoadjuvant Therapy for Soft-Tissue Sarcomas. Oncology (Williston Park). 2016 Jan; 30(1):99-106. PMID: 26791852.
    View in: PubMed
  38. Yamasaki A, Mise Y, Mise Y, Lee JE, Aloia TA, Katz MH, Chang GJ, Lillemoe KD, Raut CP, Conrad C. Musical preference correlates closely to professional roles and specialties in operating room: A multicenter cross-sectional cohort study with 672 participants. Surgery. 2016 May; 159(5):1260-8. PMID: 26706609.
    View in: PubMed
  39. Mak KS, Phillips JG, Barysauskas CM, Lee LK, Mannarino EG, Van Benthuysen L, Raut CP, Mullen JT, Fairweather M, DeLaney TF, Baldini EH. Acute gastrointestinal toxicity and bowel bag dose-volume parameters for preoperative radiation therapy for retroperitoneal sarcoma. Pract Radiat Oncol. 2016 Sep-Oct; 6(5):360-366. PMID: 27009922.
    View in: PubMed
  40. Baldini EH, Bosch W, Kane JM, Abrams RA, Salerno KE, Deville C, Raut CP, Petersen IA, Chen YL, Mullen JT, Millikan KW, Karakousis G, Kendrick ML, DeLaney TF, Wang D. Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists. Ann Surg Oncol. 2015 Sep; 22(9):2846-52. PMID: 26018727; PMCID: PMC4684182.
  41. Goldberg JM, Fisher DE, Demetri GD, Neuberg D, Allsop SA, Fonseca C, Nakazaki Y, Nemer D, Raut CP, George S, Morgan JA, Wagner AJ, Freeman GJ, Ritz J, Lezcano C, Mihm M, Canning C, Hodi FS, Dranoff G. Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines. Clin Cancer Res. 2015 Jul 15; 21(14):3178-86. PMID: 25805798.
    View in: PubMed
  42. Chikarmane SA, Gombos EC, Jagadeesan J, Raut C, Jagannathan JP. MRI findings of radiation-associated angiosarcoma of the breast (RAS). J Magn Reson Imaging. 2015 Sep; 42(3):763-70. PMID: 25504856; PMCID: PMC4539138.
  43. Lane JD, Pomahac B, Raut CP, Baldini EH, Devlin PM. High-dose-rate Interstitial Brachytherapy Boost with a Pedicled Latissimus Dorsi Myocutaneous Flap for Myxofibrosarcoma of the Arm. Plast Reconstr Surg Glob Open. 2014 Oct; 2(10):e229. PMID: 25426346; PMCID: PMC4236374.
  44. Fairweather M, Wang J, Devlin PM, Hansen J, Baldini EH, Ready JE, Sugarbaker DJ, Bertagnolli MM, Raut CP. Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomas. Ann Surg Oncol. 2015 May; 22(5):1455-63. PMID: 25341749.
    View in: PubMed
  45. Fairweather M, Raut CP. Surgical management of GIST and intra-abdominal visceral leiomyosarcomas. J Surg Oncol. 2015 Apr; 111(5):562-9. PMID: 25335830.
    View in: PubMed
  46. Pan E, Goldberg SI, Chen YL, Giraud C, Hornick JL, Nielsen GP, Hornicek FJ, Raut CP, DeLaney TF, Baldini EH. Role of post-operative radiation boost for soft tissue sarcomas with positive margins following pre-operative radiation and surgery. J Surg Oncol. 2014 Dec; 110(7):817-22. PMID: 25111884.
    View in: PubMed
  47. Bellera CA, Penel N, Ouali M, Bonvalot S, Casali PG, Nielsen OS, Delannes M, Litière S, Bonnetain F, Dabakuyo TS, Benjamin RS, Blay JY, Bui BN, Collin F, Delaney TF, Duffaud F, Filleron T, Fiore M, Gelderblom H, George S, Grimer R, Grosclaude P, Gronchi A, Haas R, Hohenberger P, Issels R, Italiano A, Jooste V, Krarup-Hansen A, Le Péchoux C, Mussi C, Oberlin O, Patel S, Piperno-Neumann S, Raut C, Ray-Coquard I, Rutkowski P, Schuetze S, Sleijfer S, Stoeckle E, Van Glabbeke M, Woll P, Gourgou-Bourgade S, Mathoulin-Pélissier S. Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†. Ann Oncol. 2015 May; 26(5):865-72. PMID: 25070543.
    View in: PubMed
  48. Kneisl JS, Coleman MM, Raut CP. Outcomes in the management of adult soft tissue sarcomas. J Surg Oncol. 2014 Oct; 110(5):527-38. PMID: 24965077.
    View in: PubMed
  49. Baldini EH, Raut C. Radiation therapy for extremity soft tissue sarcoma: in the absence of a clear survival benefit, why do we give it? Ann Surg Oncol. 2014 Aug; 21(8):2463-5. PMID: 24838365.
    View in: PubMed
  50. Wang Y, Marino-Enriquez A, Bennett RR, Zhu M, Shen Y, Eilers G, Lee JC, Henze J, Fletcher BS, Gu Z, Fox EA, Antonescu CR, Fletcher CD, Guo X, Raut CP, Demetri GD, van de Rijn M, Ordog T, Kunkel LM, Fletcher JA. Dystrophin is a tumor suppressor in human cancers with myogenic programs. Nat Genet. 2014 Jun; 46(6):601-6. PMID: 24793134; PMCID: PMC4225780.
  51. Fiore M, Coppola S, Cannell AJ, Colombo C, Bertagnolli MM, George S, Le Cesne A, Gladdy RA, Casali PG, Swallow CJ, Gronchi A, Bonvalot S, Raut CP. Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk. Ann Surg. 2014 May; 259(5):973-8. PMID: 24477160.
    View in: PubMed
  52. Gronchi A, Colombo C, Raut CP. Surgical management of localized soft tissue tumors. Cancer. 2014 Sep 01; 120(17):2638-48. PMID: 24752977.
    View in: PubMed
  53. Maynard MA, Marino-Enriquez A, Fletcher JA, Dorfman DM, Raut CP, Yassa L, Guo C, Wang Y, Dorfman C, Feldman HA, Frates MC, Song H, Jugo RH, Taguchi T, Hershman JM, Larsen PR, Huang SA. Thyroid hormone inactivation in gastrointestinal stromal tumors. N Engl J Med. 2014 Apr 03; 370(14):1327-34. PMID: 24693892.
    View in: PubMed
  54. Serrano C, Nucci MR, Tirumani SH, Raut CP, George S. Hormone dependency in metastatic low-grade leiomyosarcoma following uterine smooth muscle tumour of uncertain malignant potential. BMJ Case Rep. 2014 Mar 27; 2014. PMID: 24675802; PMCID: PMC3975512.
  55. Korenkov MK, Hong NJ, Raut CP. Individual surgery for gastric gastrointestinal stromal tumors. Surg Technol Int. 2014 Mar; 24:139-45. PMID: 24700222.
    View in: PubMed
  56. Look Hong NJ, Chang SL, Raut CP. The economic impact of cytoreductive surgery and tyrosine kinase inhibitor therapy in the treatment of advanced gastrointestinal stromal tumours: a Markov chain decision analysis. Eur J Cancer. 2014 Jan; 50(2):397-405. PMID: 24215847.
    View in: PubMed
  57. Tirumani SH, Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH, Raut CP. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection. Eur J Surg Oncol. 2014 Apr; 40(4):420-8. PMID: 24238762.
    View in: PubMed
  58. Keung EZ, Hornick JL, Bertagnolli MM, Baldini EH, Raut CP. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery. J Am Coll Surg. 2014 Feb; 218(2):206-17. PMID: 24315890.
    View in: PubMed
  59. Cheng JM, Tirumani SH, Shinagare AB, Jagannathan JP, Hornick JL, Raut CP, Ramaiya NH. MDCT of primary, locally recurrent, and metastatic duodenal gastrointestinal stromal tumours (GISTs): a single institution study of 25 patients with review of literature. Clin Radiol. 2014 Feb; 69(2):137-44. PMID: 24161459.
    View in: PubMed
  60. Gronchi A, Raut CP. Treatment of localized sarcomas. Hematol Oncol Clin North Am. 2013 Oct; 27(5):921-38. PMID: 24093168.
    View in: PubMed
  61. Raut CP, Gronchi A. Cytoreductive surgery in advanced GIST: timing is everything. Ann Surg Oncol. 2013 Dec; 20(13):4059-60. PMID: 24081799.
    View in: PubMed
  62. Khandekar MJ, Raut CP, Hornick JL, Wang Q, Alexander BM, Baldini EH. Paratesticular liposarcoma: unusual patterns of recurrence and importance of margins. Ann Surg Oncol. 2013 Jul; 20(7):2148-55. PMID: 23591942.
    View in: PubMed
  63. Iasonos A, Keung EZ, Zivanovic O, Mancari R, Peiretti M, Nucci M, George S, Colombo N, Carinelli S, Hensley ML, Raut CP. External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma. Cancer. 2013 May 15; 119(10):1816-22. PMID: 23456762; PMCID: PMC4044863.
  64. McBride SM, Raut CP, Lapidus M, Devlin PM, Marcus KJ, Bertagnolli M, George S, Baldini EH. Locoregional recurrence after preoperative radiation therapy for retroperitoneal sarcoma: adverse impact of multifocal disease and potential implications of dose escalation. Ann Surg Oncol. 2013 Jul; 20(7):2140-7. PMID: 23392853.
    View in: PubMed
  65. Koch MR, Jagannathan JP, Shinagare AB, Krajewski KM, Raut CP, Hornick JL, Ramaiya NH. Imaging features of primary anorectal gastrointestinal stromal tumors with clinical and pathologic correlation. Cancer Imaging. 2013 Feb 08; 12:557-65. PMID: 23400107; PMCID: PMC3569670.
  66. Baldini EH, Lapidus MR, Wang Q, Manola J, Orgill DP, Pomahac B, Marcus KJ, Bertagnolli MM, Devlin PM, George S, Abraham J, Ferrone ML, Ready JE, Raut CP. Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface. Ann Surg Oncol. 2013 May; 20(5):1494-9. PMID: 23242820.
    View in: PubMed
  67. Ravegnini G, Mariño-Enriquez A, Slater J, Eilers G, Wang Y, Zhu M, Nucci MR, George S, Angelini S, Raut CP, Fletcher JA. MED12 mutations in leiomyosarcoma and extrauterine leiomyoma. Mod Pathol. 2013 May; 26(5):743-9. PMID: 23222489.
    View in: PubMed
  68. Gronchi A, Raut CP. Optimal approach to sporadic desmoid tumors: from radical surgery to observation. Time for a consensus? Ann Surg Oncol. 2012 Dec; 19(13):3995-7. PMID: 22961405.
    View in: PubMed
  69. Morgan EA, Kozono DE, Wang Q, Mery CM, Butrynski JE, Baldini EH, George S, Nascimento AF, Raut CP. Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Ann Surg Oncol. 2012 Nov; 19(12):3801-8. PMID: 22890593.
    View in: PubMed
  70. Colombo C, Ronellenfitsch U, Yuxin Z, Rutkowski P, Miceli R, Bylina E, Hohenberger P, Raut CP, Gronchi A. Clinical, pathological and surgical characteristics of duodenal gastrointestinal stromal tumor and their influence on survival: a multi-center study. Ann Surg Oncol. 2012 Oct; 19(11):3361-7. PMID: 22843188.
    View in: PubMed
  71. Pedroso FE, Raut CP, Xiao H, Yeo CJ, Koniaris LG. Has the survival rate for surgically resected gastric gastrointestinal stromal tumors improved in the tyrosine kinase inhibitor era? Ann Surg Oncol. 2012 Jun; 19(6):1748-58. PMID: 22290567.
    View in: PubMed
  72. Bonvalot S, Raut CP, Pollock RE, Rutkowski P, Strauss DC, Hayes AJ, Van Coevorden F, Fiore M, Stoeckle E, Hohenberger P, Gronchi A. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol. 2012 Sep; 19(9):2981-91. PMID: 22476756.
    View in: PubMed
  73. Look Hong NJ, Pandalai PK, Hornick JL, Shekar PS, Harmon DC, Chen YL, Butrynski JE, Baldini EH, Raut CP. Cardiac angiosarcoma management and outcomes: 20-year single-institution experience. Ann Surg Oncol. 2012 Aug; 19(8):2707-15. PMID: 22476752.
    View in: PubMed
  74. Gronchi A, Raut CP. The combination of surgery and imatinib in GIST: a reality for localized tumors at high risk, an open issue for metastatic ones. Ann Surg Oncol. 2012 Apr; 19(4):1051-5. PMID: 22207052.
    View in: PubMed
  75. Grover S, Ashley SW, Raut CP. Small intestine gastrointestinal stromal tumors. Curr Opin Gastroenterol. 2012 Mar; 28(2):113-23. PMID: 22157511.
    View in: PubMed
  76. Wang J, Dang P, Raut CP, Pandalai PK, Maduekwe UN, Rattner DW, Lauwers GY, Yoon SS. Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg. 2012 Mar; 255(3):478-85. PMID: 22330040.
    View in: PubMed
  77. Raut CP, Boucher Y, Duda DG, Morgan JA, Quek R, Ancukiewicz M, Lahdenranta J, Eder JP, Demetri GD, Jain RK. Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948). PLoS One. 2012; 7(2):e26331. PMID: 22347360; PMCID: PMC3274514.
  78. Hu YY, Peyre SE, Arriaga AF, Osteen RT, Corso KA, Weiser TG, Swanson RS, Ashley SW, Raut CP, Zinner MJ, Gawande AA, Greenberg CC. Postgame analysis: using video-based coaching for continuous professional development. J Am Coll Surg. 2012 Jan; 214(1):115-24. PMID: 22192924; PMCID: PMC3287077.
  79. Ferrone ML, Raut CP. Modern surgical therapy: limb salvage and the role of amputation for extremity soft-tissue sarcomas. Surg Oncol Clin N Am. 2012 Apr; 21(2):201-13. PMID: 22365515.
    View in: PubMed
  80. Shinagare AB, Ramaiya NH, Jagannathan JP, Krajewski KM, Giardino AA, Butrynski JE, Raut CP. A to Z of desmoid tumors. AJR Am J Roentgenol. 2011 Dec; 197(6):W1008-14. PMID: 22109314.
    View in: PubMed
  81. Giardino AA, Ramaiya NH, Shinagare AB, Jagannathan JP, Stachler MD, Raut CP. Case report: Calcifying fibrous tumor presenting as an asymptomatic pelvic mass. Indian J Radiol Imaging. 2011 Oct; 21(4):306-8. PMID: 22223947; PMCID: PMC3249950.
  82. Gutierrez A, Snyder EL, Marino-Enriquez A, Zhang YX, Sioletic S, Kozakewich E, Grebliunaite R, Ou WB, Sicinska E, Raut CP, Demetri GD, Perez-Atayde AR, Wagner AJ, Fletcher JA, Fletcher CD, Look AT. Aberrant AKT activation drives well-differentiated liposarcoma. Proc Natl Acad Sci U S A. 2011 Sep 27; 108(39):16386-91. PMID: 21930930; PMCID: PMC3182699.
  83. Valero MG, Raut CP, Lotfi P, Golshan M. Atypical lipomatous tumor of the breast. J Clin Oncol. 2011 Nov 01; 29(31):e766-8. PMID: 21931026.
    View in: PubMed
  84. Liu R, Wolinsky JB, Catalano PJ, Chirieac LR, Wagner AJ, Grinstaff MW, Colson YL, Raut CP. Paclitaxel-eluting polymer film reduces locoregional recurrence and improves survival in a recurrent sarcoma model: a novel investigational therapy. Ann Surg Oncol. 2012 Jan; 19(1):199-206. PMID: 21769471.
    View in: PubMed
  85. Raut CP, George S, Hornick JL, Butrynski JE, Morgan JA, Ready J, Nascimento AF, Fletcher CD, Demetri GD, Baldini EH. High rates of histopathologic discordance in sarcoma with implications for clinical care. J Clin Oncol. 2011 May 20; 29(15_suppl):10065. PMID: 28021289.
    View in: PubMed
  86. Raut CP, Kulke MH. Targeted therapy in advanced well-differentiated neuroendocrine tumors. Oncologist. 2011; 16(3):286-95. PMID: 21346024; PMCID: PMC3228104.
  87. Winer JH, Raut CP. Management of recurrent gastrointestinal stromal tumors. J Surg Oncol. 2011 Dec; 104(8):915-20. PMID: 21337345.
    View in: PubMed
  88. Haglund KE, Raut CP, Nascimento AF, Wang Q, George S, Baldini EH. Recurrence patterns and survival for patients with intermediate- and high-grade myxofibrosarcoma. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):361-7. PMID: 20951504.
    View in: PubMed
  89. Raut CP, Swallow CJ. Are radical compartmental resections for retroperitoneal sarcomas justified? Ann Surg Oncol. 2010 Jun; 17(6):1481-4. PMID: 20401636.
    View in: PubMed
  90. Demetri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, Pisters PW, Raut CP, Riedel RF, Schuetze S, Sundar HM, Trent JC, Wayne JD. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010 Apr; 8 Suppl 2:S1-41; quiz S42-4. PMID: 20457867; PMCID: PMC4103754.
  91. Nathan H, Raut CP, Thornton K, Herman JM, Ahuja N, Schulick RD, Choti MA, Pawlik TM. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system. Ann Surg. 2009 Dec; 250(6):970-6. PMID: 19644351; PMCID: PMC3099434.
  92. Raut CP, Wang Q, Manola J, Morgan JA, George S, Wagner AJ, Butrynski JE, Fletcher CD, Demetri GD, Bertagnolli MM. Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumor treated with sunitinib malate. Ann Surg Oncol. 2010 Feb; 17(2):407-15. PMID: 19898902.
    View in: PubMed
  93. Mery CM, George S, Bertagnolli MM, Raut CP. Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival. Cancer. 2009 Sep 15; 115(18):4055-63. PMID: 19526590.
    View in: PubMed
  94. Raut CP, Nucci MR, Wang Q, Manola J, Bertagnolli MM, Demetri GD, Morgan JA, Muto MG, Fletcher CD, George S. Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma. Eur J Cancer. 2009 Nov; 45(16):2818-24. PMID: 19647426.
    View in: PubMed
  95. Mitchell CC, Ashley SW, Orgill DP, Zinner MJ, Raut CP. Gauging surgeons' understanding and perceptions of an academic incentive plan. Arch Surg. 2009 May; 144(5):421-6; discussion 426. PMID: 19451483.
    View in: PubMed
  96. Lowenthal MS, Sadow PM, Raut C, Metzler EC. Intraoperative diagnosis of a functional paraganglioma presenting as a gastrointestinal stromal cell tumor (GIST). J Clin Anesth. 2009 Feb; 21(1):57-60. PMID: 19232943.
    View in: PubMed
  97. Raut CP, Bertagnolli MM. Controversies in the surgical management of GIST in the era of imatinib. Oncology (Williston Park). 2009 Jan; 23(1):69, 74-6. PMID: 19283924.
    View in: PubMed
  98. Nascimento AF, Raut CP, Fletcher CD. Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic. Am J Surg Pathol. 2008 Dec; 32(12):1896-904. PMID: 18813119.
    View in: PubMed
  99. Irani JL, Cutler CS, Whang EE, Clancy TE, Russell S, Swanson RS, Ashley SW, Zinner MJ, Raut CP. Severe acute gastrointestinal graft-vs-host disease: an emerging surgical dilemma in contemporary cancer care. Arch Surg. 2008 Nov; 143(11):1041-5; discussion 1046. PMID: 19015460.
    View in: PubMed
  100. Maker AV, Lee LS, Raut CP, Clancy TE, Swanson RS. Cytology from pancreatic cysts has marginal utility in surgical decision-making. Ann Surg Oncol. 2008 Nov; 15(11):3187-92. PMID: 18766406.
    View in: PubMed
  101. Raut CP. Review. Gastroenterol Hepatol (N Y). 2008 Sep; 4(9):657-9. PMID: 22798751; PMCID: PMC3394479.
  102. Bertagnolli MM, Morgan JA, Fletcher CD, Raut CP, Dileo P, Gill RR, Demetri GD, George S. Multimodality treatment of mesenteric desmoid tumours. Eur J Cancer. 2008 Nov; 44(16):2404-10. PMID: 18706807.
    View in: PubMed
  103. Irani JL, Ashley SW, Brooks DC, Osteen RT, Raut CP, Russell S, Swanson RS, Whang EE, Zinner MJ, Clancy TE. Distal pancreatectomy is not associated with increased perioperative morbidity when performed as part of a multivisceral resection. J Gastrointest Surg. 2008 Dec; 12(12):2177-82. PMID: 18677539.
    View in: PubMed
  104. Nascimento AF, Raut CP. Diagnosis and management of pleomorphic sarcomas (so-called "MFH") in adults. J Surg Oncol. 2008 Mar 15; 97(4):330-9. PMID: 18286476.
    View in: PubMed
  105. Raut CP, Ashley SW. How I do it: surgical management of gastrointestinal stromal tumors. J Gastrointest Surg. 2008 Sep; 12(9):1592-9. PMID: 18317848.
    View in: PubMed
  106. Raut CP, DeMatteo RP. Prognostic factors for primary GIST: prime time for personalized therapy? Ann Surg Oncol. 2008 Jan; 15(1):4-6. PMID: 17932720.
    View in: PubMed
  107. Ito H, Hornick JL, Bertagnolli MM, George S, Morgan JA, Baldini EH, Wagner AJ, Demetri GD, Raut CP. Leiomyosarcoma of the inferior vena cava: survival after aggressive management. Ann Surg Oncol. 2007 Dec; 14(12):3534-41. PMID: 17896156.
    View in: PubMed
  108. Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwang R, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg. 2007 Jul; 246(1):52-60. PMID: 17592291; PMCID: PMC1899216.
  109. Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, Corless CL, Debiec-Rychter M, DeMatteo RP, Ettinger DS, Fisher GA, Fletcher CD, Gronchi A, Hohenberger P, Hughes M, Joensuu H, Judson I, Le Cesne A, Maki RG, Morse M, Pappo AS, Pisters PW, Raut CP, Reichardt P, Tyler DS, Van den Abbeele AD, von Mehren M, Wayne JD, Zalcberg J. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw. 2007 Jul; 5 Suppl 2:S1-29; quiz S30. PMID: 17624289.
    View in: PubMed
  110. Heinrich MC, Corless CL, Leigl B, Fletcher CD, Raut CP, Donsky R, Bertagnolli MM, Harlow A, Demetri GD, Fletcher JA. Mechanisms of sunitinib malate resistance in gastrointestinal stromal tumors. 2007.
  111. Smith DL, Elting LS, Learn PA, Raut CP, Mansfield PF. Factors influencing the volume-outcome relationship in gastrectomies: a population-based study. Ann Surg Oncol. 2007 Jun; 14(6):1846-52. PMID: 17406947.
    View in: PubMed
  112. Parrett BM, Orgill DP, Marsee DK, Freedman AS, Raut CP. Novel presentation of intraneural nodular fasciitis of the sciatic nerve. J Peripher Nerv Syst. 2007 Mar; 12(1):61-3. PMID: 17374106.
    View in: PubMed
  113. Raut CP, Morgan JA, Ashley SW. Current issues in gastrointestinal stromal tumors: incidence, molecular biology, and contemporary treatment of localized and advanced disease. Curr Opin Gastroenterol. 2007 Mar; 23(2):149-58. PMID: 17268243.
    View in: PubMed
  114. Maker A, Lee L, Raut CP, Clancy T, Russell S, Swanson R. Pancreatic cystic neoplasms: limitations of endoscopic-guided fine-needle aspiration in surgical decision making. 2007.
  115. Raut CP, Varadhachary G, Wang H, Tamm E, Fleming JB, Evans DB. Margin status following pancreaticoduodenectomy for pancreatic adenocarcinoma: implication of R status. Diseases of the Pancreas. Beger H, Matsuno, Cameron J, editors. 2007.
  116. Raut CP, Morgan JA, Quigley MT, George S, Wagner AJ, Demetri GD, Bertagnolli MM. Perioperative sunitinib dosing around extensive resections of imatinib-resistant metastatic gastrointestinal stromal tumors. 2007.
  117. Mery C, George S, Raut CP. Development of secondary sarcoma after radiation in patients with breast cancer. 2007.
  118. Ito H, Hornick J, Bertagnolli MM, Morgan JA, George S, Baldini EH, Wagner AJ, Demetri GD, Raut CP. Leiomyosarcoma of the inferior vena cava: long-term outcomes of multimodality therapy. 2007.
  119. Mery C, Zellos L, Raut CP. Peritoneal mesothelioma: incidence and risk factors for survival. 2007.
  120. Kulke MH, Raut CP. Neuroendocrine tumors of the gastrointestinal tract. Gastrointestinal Oncology, Principles and Practice. Kelsen DP, editor. 2007.
  121. Raut CP, Dileo P, Morgan JA, Wagner AJ, Demetri GD, George S, Bertagnolli MM. Long-term disease control in patients (pts) with desmoid fibromatosis managed with multimodality therapy. 2006.
  122. Raut CP, Albert M. Brachytherapy for Sarcoma. Brachytherapy: Techniques and Applications. Devlin P, editor. 2006.
  123. Irani JL, Cutler CS, Ashley SW, Zinner MJ, Whang EE, Raut CP. Gastrointestinal graft-versus-host disease: an emerging surgical dilemma in contemporary cancer care. 2006.
  124. Raut CP, Pisters PW. Retroperitoneal sarcomas: Combined-modality treatment approaches. J Surg Oncol. 2006 Jul 01; 94(1):81-7. PMID: 16788949.
    View in: PubMed
  125. Raut CP, Van den Abbeele A, Ramaiya N, Morgan JA, George, S, Quigley MT, Dollard AM, Bertagnolli MM, Baum CM, Demetri GD. PET imaging demonstrates two patterns of response in GIST patients benefiting from long-term sunitinib therapy. 2006.
  126. Raut CP, Van Den Abbeele A, Ramaiya N, Morgan JA, George S, Quigley MT, Dollard AM, Bertagnolli MM, Baum C, Demetri GD. Patterns of PET response after long-term sunitinib therapy in patients (pts) with imatinib (IM)-resistant gastrointestinal stromal tumors (GIST). J Clin Oncol. 2006 Jun 20; 24(18_suppl):9547. PMID: 27952946.
    View in: PubMed
  127. Raut CP, Van den Abbeele A, Ramaiya N, Morgan JA, George, S, Quigley MT, Dollard AM, Bertagnolli MM, Baum CM, Demetri GD. Patterns of PET response after long-term sunitinib therapy in patients with imatinib-resistant gastrointestinal stromal tumors (GIST). J Clin Oncol 2006;24(18S):531S (abstract 9547). 2006.
  128. Raut CP, Kulke MH, Glickman JN, Swanson RS, Ashley SW. Carcinoid tumors. Curr Probl Surg. 2006 Jun; 43(6):383-450. PMID: 16781906.
    View in: PubMed
  129. Raut CP, Posner M, Desai J, Morgan JA, George S, Zahrieh D, Fletcher CD, Demetri GD, Bertagnolli MM. Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. J Clin Oncol. 2006 May 20; 24(15):2325-31. PMID: 16710031.
    View in: PubMed
  130. Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol. 2006 Apr; 13(4):582-94. PMID: 16523362.
    View in: PubMed
  131. Tamm EP, Loyer EM, Faria S, Raut CP, Evans DB, Wolff RA, Crane CH, Dubrow RA, Charnsangavej C. Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. Abdom Imaging. 2006 Sep-Oct; 31(5):568-74. PMID: 16465578.
    View in: PubMed
  132. Raut CP, Posner M, Desai J, Morgan JA, George S, Zahrieh D, Fletcher CDM, Demetri GD, Bertagnolli MM. Surgical management of gastrointestinal stromal tumors (GIST) following treatment with targeted systemic therapy using kinase inhibitors. 2006.
  133. Trent J, Demetri GD, Corless C, Raut CP. Multimodality Management of GIST. 2006.
  134. Raut CP, Hornick JL, Bertagnolli MM. Advanced gastrointestinal stromal tumor: potential benefits of aggressive surgery combined with targeted tyrosine kinase inhibitor therapy. Am J Hematol/Oncol. 2006; 5(12):707-12.
  135. Raut CP, La Casce AS. Lymphoma of the Small Bowel. Advanced Therapy in Surgical Oncology. Pollock R, Curley SA, Ross MI, Perrier N, editors. 2006.
  136. Raut, CP. Epidemiology of Sarcoma. Advanced Therapy in Surgical Oncology. Pollock R, Curley SA, Ross MI, Perrier N, editors. 2006.
  137. Raut, CP. Genetics of Sarcoma. Advanced Therapy in Surgical Oncology. Pollock R, Curley SA, Ross MI, Perrier N, editors. 2006.
  138. Raut CP, Desai J, Morgan JA, George S, Posner M, Zahrieh D, Fletcher CDM, Demetri GD, Bertagnolli MM. Surgical management of gastrointestinal stromal tumors (GIST) following KIT-directed therapy. 2005.
  139. Raut CP, Hunt KK, Akins JS, Daley MD, Ross MI, Singletary SE, Marshall GD, Meric-Bernstam F, Babiera G, Feig BW, Ames FC, Kuerer HM. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer. 2005 Aug 15; 104(4):692-9. PMID: 15981283.
    View in: PubMed
  140. Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Cremona F, Vallone P, Mastro A, Fornage BD, Curley SA. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol. 2005 Aug; 12(8):616-28. PMID: 15965731.
    View in: PubMed
  141. Davis DW, Takamori R, Raut CP, Xiong HQ, Herbst RS, Stadler WM, Heymach JV, Demetri GD, Rashid A, Shen Y, Wen S, Abbruzzese JL, McConkey DJ. Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):678-89. PMID: 15701856.
    View in: PubMed
  142. Raut CP, Vauthey JN. Resection of the mid-common bile duct. Atlas of Upper Abdominal Surgery. Clavien PA, Sarr MG, Fong Y, editors. 2005.
  143. Raut CP, Ellis LM. Anti-angiogenic therapy in pancreatic cancer. Pancreatic Cancer. Von Hoff DD, Evans DB, Hruban RH, editors. 2005.
  144. Raut CP, Pawlik TM, Rodriguez-Bigas MA. Clinicopathologic features in colorectal cancer patients with microsatellite instability. Mutat Res. 2004 Dec 21; 568(2):275-82. PMID: 15542114.
    View in: PubMed
  145. Raut CP, Nawrocki S, Lashinger LM, Davis DW, Khanbolooki S, Xiong H, Ellis LM, McConkey DJ. Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts. Cancer Biol Ther. 2004 Dec; 3(12):1217-24. PMID: 15477758.
    View in: PubMed
  146. Raut CP, Ashley SW. Surgical palliation for pancreatic cancer. 2004.
  147. Raut CP. Ablative therapy in unresectable hepatocellular carcinoma. 2004.
  148. Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Gomez HF, Sun CC, Crane CH, Wolff RA, Evans DB. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg. 2004 Dec; 8(8):935-49; discussion 949-50. PMID: 15585381.
    View in: PubMed
  149. Raut CP, McConkey DJ, Abbruzzese JL. Strategies for chemoprevention in pancreatic cancer. Cancer Chemoprevention, Vol. 2: Strategies for Cancer Chemoprevention. Kelloff GJ, Hawk ET, Sigman CC, editors. 2004; 2.
  150. Raut CP, Evans DB, Crane CH, Pisters PW, Wolff RA. Neoadjuvant therapy for resectable pancreatic cancer. Surg Oncol Clin N Am. 2004 Oct; 13(4):639-61, ix. PMID: 15350939.
    View in: PubMed
  151. Raut CP, Lee JE. Unusual functioning endocrine tumors. Curr Treat Options Oncol. 2004 Aug; 5(4):327-34. PMID: 15233909.
    View in: PubMed
  152. Smith DL, Raut CP, Elting LS, Mansfield PF. Volume-outcome relationship of gastrectomy for cancer in Texas. J Clin Oncol. 2004 Jul 15; 22(14_suppl):6091. PMID: 28014982.
    View in: PubMed
  153. Raut CP, Takamori RK, Davis DW, Sweeney-Gotsch B, O'Reilly MS, McConkey DJ. Direct effects of recombinant human endostatin on tumor cell IL-8 production are associated with increased endothelial cell apoptosis in an orthotopic model of human pancreatic cancer. Cancer Biol Ther. 2004 Jul; 3(7):679-87. PMID: 15197351.
    View in: PubMed
  154. Smith DL, Raut CP, Elting LS, Mansfield PF. Volume-outcome relationship of gastrectomy for cancer in Texas. J Clin Oncol 2004;22(14S):541S (abstract 6091). 2004.
  155. Tseng JF, Pisters PWT, Lee JE, Vauthey JN, Abdalla EK, Raut CP, Gomez HF, Sun CC, Crane CH, Wolff RA, Evans DB. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. 2004.
  156. Raut CP, Tseng JF, Sun C, Scoggins CR, Cleary KR, Gomez HF, Vauthey JN, Lee JE, Pisters PWT, Evans DB. Pancreaticoduodenectomy for pancreatic adenocarcinoma: impact of margin status on pattern of failure and survival. 2004.
  157. Curley SA, Marra P, Beaty K, Ellis LM, Vauthey JN, Abdalla EK, Scaife C, Raut C, Wolff R, Choi H, Loyer E, Vallone P, Fiore F, Scordino F, De Rosa V, Orlando R, Pignata S, Daniele B, Izzo F. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004 Apr; 239(4):450-8. PMID: 15024305; PMCID: PMC1356249.
  158. Raut CP, Marra P, Izzo F, Ellis LM, Vauthey JN, Abdalla EK, Scaife CL, Curley SA. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg Onc 2004;11(2):S112. 2004; 11(2):S112.
  159. Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Danielle B, Vallone P, Fornage B, Curley SA. Significant long-term survival in unresectable hepatocellular carcinoma treated with radiofrequency ablation. Ann Surg Onc 2004;11(2):S73. 2004; 11(2):S73.
  160. Raut CP, Cleary KR, Pisters PWT, Vauthey JN, Lee JE, Evans DB. Intraductal papillary mucinous neoplasm of the pancreas: importance of accurate histologic evaluation. Ann Surg Onc 2004;11(2):S55. 2004; 11(2):S55.
  161. Raut CP, Daley MD, Hunt KK, Akins J, Ross MI, Singletary SE, Marshall GD, Meric-Bernstam F, Babiera G, Feig BW, Ames FC, Kuerer HM. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol. 2004 Feb 01; 22(3):567-8. PMID: 14752082.
    View in: PubMed
  162. Pawlik TM, Raut CP, Rodriguez-Bigas MA. Colorectal carcinogenesis: MSI-H versus MSI-L. Dis Markers. 2004; 20(4-5):199-206. PMID: 15528785; PMCID: PMC3839332.
  163. Raut CP, Cambria RP, LaMuraglia GM, Brewster DC, Moncure AC, Abbott WM. Surgical management of popliteal artery embolism at the turn of the millennium. Ann Vasc Surg. 2004 Jan; 18(1):79-85. PMID: 14508664.
    View in: PubMed
  164. Raut CP, Lashinger L, McConkey DJ. COX-2 regulation of a survival pathway in pancreatic cancer. J Am Coll Surg 2003;197(3S):S77. 2003; 197(3S):S77.
  165. Raut CP, Bouvet M, Lee JE, Vauthey J-N, Pisters PWT, Evans DB. Pancreaticoduodenectomy for suspected cancer: can patients with benign disease be identified prior to surgery?. 2003.
  166. Raut CP, Lashinger L, McConkey DJ. COX-2 regulation of a survival pathway in pancreatic cancer in vitro. 2003.
  167. Raut CP, Daley MD, Hunt KK, Akins J, Ross MI, Singletary SE, Marshall GD, Meric F, Babiera G, Feig BW, Ames FC, Kuerer HM. Incidence of anaphylactoid reactions during breast cancer lymphatic mapping following preoperative prophylaxis: initial results of a prospective clinical practice protocol. 2003.
  168. Raut CP, Lashinger L, McConkey DJ. Upstream regulation of COX-2 expression and downstream modulation with COX-2 inhibition in pancreatic cancer. Proc Am Assoc Cancer Res 2003;44. 2003; 44.
  169. Raut CP, Takamori R, Davis DW, O’Reilly M, McConkey DJ. Endostatin in a pancreatic cancer model. Ann Surg Onc 2003;10:S43. 2003; 10:S43.
  170. Raut CP, Fernandez-del Castillo C. Giant lipoma of the pancreas: case report and review of lipomatous lesions of the pancreas. Pancreas. 2003 Jan; 26(1):97-9. PMID: 12499926.
    View in: PubMed
  171. Raut CP, Grau AM, Staerkel GA, Kaw M, Tamm EP, Wolff RA, Vauthey JN, Lee JE, Pisters PWT, Evans DB. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg. 2003 Jan; 7(1):118-128. PMID: 12559193.
    View in: PubMed
  172. Raut CP, Grau AM, Staerkel GA, Kaw M, Tamm EP, Wolff RA, Vauthey JN, Lee JE, Pisters PWT, Evans DB. Diagnostic accuracy of EUS-FNA in patients with presumed pancreatic cancer. 2002.
  173. Raut CP, Takamori R, Davis DW, Sweeney-Gotsch B, O’Reilly M, McConkey DJ. IL-8 downregulation and endothelial cell apoptosis after endostatin treatment in an orthotopic pancreatic cancer model. Proc Am Assoc Cancer Res 2002;43:31. 2002; 43:31.
  174. Takamori RK, Raut C, Sweeney-Gotsch B, McMahon G, Ellis L, McConkey DJ. The tyrosine kinase inhibitor SU6668 inhibits tumor growth and induces endothelial cell apoptosis in an orthotopic pancreas model. Proc Am Assoc Cancer Res 2002;43:526. 2002; 43:526.
  175. Raut CP, Stephen AE, Kosovsky B. Intrauterine effects of substance abuse. Source Book of Substance Abuse and Addiction. Friedman L, Fleming NF, Roberts DH, Hyman SE, editors. 1996; 269-87.
  176. Raut CP. Regional Localization on the X Chromosome of the Turner Phenotype. 1995.
  177. Coleman MP, Németh AH, Campbell L, Raut CP, Weissenbach J, Davies KE. A 1.8-Mb YAC contig in Xp11.23: identification of CpG islands and physical mapping of CA repeats in a region of high gene density. Genomics. 1994 May 15; 21(2):337-43. PMID: 8088827.
    View in: PubMed
  178. Coleman MP, Nemeth AH, Campbell L, Raut CP, Weissenbach J, Davies KE. A 1.7Mb YAC contig in Xp11.23. 1993.
  179. Raut CP. Characterization of a Low-Copy Repeat on the Human X Chromosome. 1991.
  180. Hirst M, Nakahori Y, Knight S, Roche A, Raut C, Rack K, Flynn G, Buckle V, Bell M, Claussen U, Ludecke H, Senger G, Horsthemke G, Holland J, Bentley D, Super M, Davies K . A YAC contig across the fragile X region derived from chromosome microdissection markers. 1991.
  181. MacKinnon RN, Raut CP, Hirst MC, Rack K, Buckle V, Carter NP, Flint TJ, Roche A, Holland J, Bentley DR, Nizetic D, Davies KE. Characterization of a novel highly variable conserved repeat in the human genome. 1991.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Raut's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (438)
Explore
_
Co-Authors (115)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.